Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
<p>CAMBRIDGE, Mass., Sept. 30, 2026 /PRNewswire/ -- As population aging accelerates with demand for weight management continuing to expand, the market for GLP-1 receptor agonist (GLP-1RA) drugs is experiencing explosive growth. Tirzepatide, with annual sales of $36.507 billion in 2025, has...</p>
Read original article ↗
Related Articles
Samsung Electro-Mechanics has signed another long-term supply agreement for server components, bringing the value of its
Hyundai E&C to launch sales of Hillstate Godeok Ellist units in Pyeongtaek
Hyundai E&C is set to begin sales of units at Hillstate Godeok Ellist, an apartment complex in Godeok International New
HS Hyosung Advanced Materials to invest $100 mil. in Vietnam carpet plant
HS Hyosung Advanced Materials will invest $100 million to build a new carpet manufacturing plant in Vietnam, seeking to
Dunamu seeks to connect S. Korea with global on-chain infrastructure: CEO
The head of Dunamu, Korea's largest virtual asset exchange, said Wednesday his company hopes to connect the country's fi